DSM acquires Brazilian state-of-the-art fermentation facility from Amyris


20 Nov 2017 --- Royal DSM a global science-based company active in health, nutrition and materials and Amyris, Inc, the industrial bioscience company, have enhanced their strategic alliance through the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris' high-volume products.  

The consideration for Amyris Brasil Ltda, which owns and operates the Brotas 1 production facility, and intellectual property related to farnesene, a bio-based key intermediate for many applications, is US$58 million. 

On top of this, there is an additional value share arrangement over a three-year period amounting to US$37.5 million. In addition to the consideration upfront, there is potential for a future value share in line with Amyris' business model.

DSM will continue existing supply-agreements to Amyris and other parties and will also supply Amyris with specialty compounds until it realizes its Brotas 2 specialties production facility. 

Speedy construction 
Amyris says it is accelerating the construction of its second facility which will be dedicated to specialty products while maintaining the manufacturing process development and business support capability located in Campinas, Brazil.

The transaction is subject to the usual conditions and is expected to close in the next few months.

With the acquisition of the Brotas 1 facility, DSM adds a state-of-the-art biotechnology-based production site in Brazil to its global network, with abundant availability of sustainable raw materials, namely sugar cane, securing production capacity for its rich pipeline of sustainable and bio-based solutions. 

Having broad experience in operating large-scale fermentation plants, DSM will optimize the operational performance of the site.

The strategic alliance between DSM and Amyris started in May 2017 with an equity investment by DSM in Amyris and has since been expanded with several significant product development collaborations.  

The sale of the Brotas 1 facility, which was designed to produce high volumes of farnesene, together with the creation of a long-term production relationship for high-volume farnesene-based intermediates, will enable Amyris to focus on its core strength of developing breakthrough bioscience technologies, says DSM. 

The company will continue to target key markets and concentrate on the production of specialty products.

“Following our equity investment in Amyris and subsequent product development cooperation, I am pleased that we can add a state-of-the-art fermentation-based production facility to our network,” said Chris Goppelsroeder, President & CEO of DSM Nutritional Products.

“Our know-how in fermentation, downstream process development and large-scale manufacturing will allow us to further improve the operational performance of the facility while further strengthening our strategic alliance with Amyris.”

Amyris President & CEO, John Melo, adds how pleased the company is with the continued strategic alliance with DSM. 

“This manufacturing partnership and the sale of our Brotas 1 factory allows us to accelerate the development and manufacturing of specialty, high-performance ingredients,” he said.

“We are building a specialty plant at Brotas (Brotas 2) and also expect to complete our São Martinho plant to focus on sweeteners. The combination of these actions provides us the manufacturing footprint to meet our current demand through the next three to five years and to manage this within our funding constraints.”

“This transaction completes a planned shift from operating a plant originally designed to produce high volumes of farnesene, to producing an expanding number of high-value, specialty ingredients. This shift will allow Amyris to improve returns and cash flows in order to continue to provide sustainable growth for Amyris and its partners.”

DSM Food Specialties


Our aim is to help customers succeed in their markets through strong innovation, exceptional application expertise and insight into the many, ever-changing needs of consumers worldwide.

For food, beverage and supplement manufacturers we offer the comprehensive resources needed to provide customized solutions. Scientific excellence aside, that means a deep knowledge and understanding of markets, consumers and the defining trends in our industry. Namely:

A sharp focus on health benefits: Consumers across the world want to look and feel better. The empowerment and awareness of consumers from India to Indiana is a defining trend in food and beverage nutrition, which we meet through our family of nutritional ingredients and products.

Taste is a key qualifier: If a product doesn’t taste good it doesn’t stand much chance of success. As the world’s tastes and preferences evolve and expand, we are increasingly helping customers innovate, with exciting, authentic and regional flavors and ingredients provided in a streamlined and efficient way.

The drive for convenience: Despite the trend for health foods, time-pressed consumers are looking to buy more processed and convenience food than ever. DSM is committed to helping customers address the need for fast, high-quality products.

Food safety and quality: Our ingredients are based on solid scientific evidence and application knowledge based on decades of experience in our markets. We’re well aware that food safety and compliance is paramount for growing and ambitious food brands.

Related Articles

Business News

ADM restructures business divisions amid falling grain margins, forms Nutrition unit

20 Mar 2018 --- Archer Daniels Midland Company (ADM) has announced the realignment of its business segments across four units – Carbohydrate Solutions, Nutrition, Oilseeds and Origination. The new segments better reflect ADM’s operating structure as the company seeks ways to remain competitive in the face of persistent tight margins in the global grains sector.

Food Ingredients News

Beverage innovation: “Lighter enjoyment,” botanicals and cold brew NPD

20 Mar 2018 --- Current innovation across the beverage category is centered around health and wellbeing, as sugar reformulation and the broader idea of “lighter enjoyment” continues to dominate new product development. Globally, producers are tapping into the growing consumer demand for enjoyable soft and alcoholic drinks that have been given a clean and clear label makeover as innovators continue to dump sugar and reformulate with more natural alternatives.

Food Ingredients News

Brexit: Health advocates fear future transatlantic trade deal could undermine efforts

20 Mar 2018 --- The alliance for better food and farming, Sustain, is demanding that clear mandates with health priorities are set for any trade talks between Britain and the US amid concerns that new deals will undermine the UK’s efforts to reduce sugar consumption and import “American levels of diet-related diseases” alongside their produce.

Food Ingredients News

Frutarom reports “record-breaking results” for 2017

20 Mar 2018 --- Frutarom expects 2018 to be “another record year” as it continues to improve profitability as it posts 2017 results which show sales grew by 18.8 percent to a record US$1,362.4 million. The Israel-based flavor and fragrance company says it is progressing towards achieving its sales target of US$2.25 billion and an EBITDA margin from core activity of 23 percent in 2020.

Food Ingredients News

Cargill starts production of optimized stevia extract

20 Mar 2018 --- Cargill has officially started producing EverSweet,  a zero-calorie, next-generation sweetener made with two of the best tasting sweet compounds found in the stevia leaf, Reb M and Reb D.

More Articles